SEC Form 4 · accession 0001209191-16-124131
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Parker
Director
Period of report
May 26, 2016
Accepted (ET)
May 27, 2016 · 5:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 26, 2016 | A | 20,362 | A | — | — | Common Stock | 20,362 | 20,362 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F2100% of the restricted stock units will vest on May 26, 2017, subject to the Reporting Person's continued service to the Company on such date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.